All In Biotech

Drug Trial Radar · NCT07221578

Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Acute Anxiety in Patients With Social Anxiety Disorder

Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Sep 22, 2025

Primary completion

Dec 2026

Study completion Apr 2027

Sponsor

Lead sponsor
Vanda PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Oct 28, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in adults with social anxiety disorder.

Conditions

  • Social Anxiety Disorder (SAD)

Interventions

  • VQW-765Drug

    oral capsule

  • PlaceboDrug

    oral capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subjective Units of Distress Scale (SUDS)Time frame: 1 day

Locations

30 sites in 1 country. Site status is shown where the registry gives one.

  • Vanda Investigational Site

    Phoenix, Arizona

  • Vanda Investigational Site

    Scottsdale, Arizona

  • Vanda Investigational Site

    Encino, California

  • Vanda Investigational Site

    Mission Viejo, California

  • Vanda Investigational Site

    San Diego, California

  • Vanda Investigational Site

    San Jose, California

  • Vanda Investigational Site

    Walnut Creek, California

  • Vanda Investigational Site

    Denver, Colorado

  • Vanda Investigational Site

    Jacksonville, Florida

  • Vanda Investigational Site

    Miami, Florida

  • Vanda Investigational Site

    Orlando, Florida

  • Vanda Investigational Site

    Tampa, Florida

  • Vanda Investigational Site

    Atlanta, Georgia

  • Vanda Investigational Site

    Suwanee, Georgia

  • Vanda Investigational Site

    New Orleans, Louisiana

  • Vanda Investigational Site

    Pikesville, Maryland

  • Vanda Investigational Site

    Rockville, Maryland

  • Vanda Investigational Site

    Towson, Maryland

  • Vanda Investigational Site

    Saint Charles, Missouri

  • Vanda Investigational Site

    St Louis, Missouri

  • Vanda Investigational Site

    Las Vegas, Nevada

  • Vanda Investigational Site

    Princeton, New Jersey

  • Vanda Investigational Site

    Albuquerque, New Mexico

  • Vanda Investigational Site

    New York, New York

  • Vanda Investigational Site

    New York, New York

  • Vanda Investigational Site

    Charlotte, North Carolina

  • Vanda Investigational Site

    Wilmington, North Carolina

  • Vanda Investigational Site

    Houston, Texas

  • Vanda Investigational Site

    Wichita Falls, Texas

  • Vanda Investigational Site

    Orem, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.